History of Present Illness: [**Known firstname 95455**] [**Known lastname 95456**] is a 71-year-old right-handed man with DM, CAD s/p IMI, chronic diastolic CHF, malignant hypertension, and recent diagnosis of right frontotemporal GBM, s/p biopsy on [**2131-9-18**] who presented to the [**Hospital6 33**] ED from rehabilitation after complaining of SOB and headache.
He was then given Decadron 10 mg IV and Ativan 2 mg IV.
He also received vecuronium 10 mg IV x 2, etomidate 20 mg IV, and succhinylcholine 100 mg IV, and intubated for respiratory failure attributed to acute CHF based on chest X-ray.
He also received 2" nitro paste and Lasix 80 mg IV.
He was also hypotensive to 60/p systolic en route, up to SBP 89 after removal of nitro paste.
Blood cultures sent, given levaquin 750 mg IV, started on propofol gtt.
Past Medical History: -R frontotemporal GBM WHO Grade IV s/p biopsy [**2131-9-27**], plan to start protocol using hypofractionated involved-field XRT with temozolomide and Cyberknife boost -Malignant HTN -CAD s/p IMI -Chronic diastolic CHF -PAF (ED visit [**7-25**]) -DM -Anxiety  Social History: Resident of [**First Name5 (NamePattern1) 4542**] [**Last Name (NamePattern1) 19207**] & Nursing Center in [**Location (un) 38**], MA.
He worked for USSR space program and NASA.
Pertinent Results: [**2131-10-13**] 02:50AM URINE  RBC-1 WBC-1 BACTERIA-NONE YEAST-NONE EPI-1 [**2131-10-13**] 02:50AM URINE  BLOOD-TR NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-0.2 PH-5.0 LEUK-NEG [**2131-10-13**] 02:50AM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.010 [**2131-10-13**] 02:50AM   FIBRINOGE-418* [**2131-10-13**] 02:50AM   PLT COUNT-339 [**2131-10-13**] 02:50AM   PT-12.4 PTT-24.0 INR(PT)-1.0 [**2131-10-13**] 02:50AM   WBC-13.7* RBC-3.68* HGB-10.9* HCT-33.8* MCV-92 MCH-29.6 MCHC-32.3 RDW-16.2* [**2131-10-13**] 02:50AM URINE  bnzodzpn-POS barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG [**2131-10-13**] 02:50AM URINE  GR HOLD-HOLD [**2131-10-13**] 02:50AM URINE  HOURS-RANDOM [**2131-10-13**] 02:50AM URINE  HOURS-RANDOM [**2131-10-13**] 02:50AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2131-10-13**] 02:50AM   cTropnT-0.04* [**2131-10-13**] 02:50AM   CK-MB-4 cTropnT-0.04* proBNP-[**2147**]* [**2131-10-13**] 02:50AM   LIPASE-15 [**2131-10-13**] 02:50AM   CK(CPK)-126 [**2131-10-13**] 02:50AM   estGFR-Using this [**2131-10-13**] 02:50AM   UREA N-28* CREAT-1.0 [**2131-10-13**] 02:51AM   LACTATE-1.1 [**2131-10-13**] 02:51AM   TYPE-ART INTUBATED-INTUBATED VENT-CONTROLLED [**2131-10-13**] 03:03AM   freeCa-1.10* [**2131-10-13**] 03:03AM   HGB-11.5* calcHCT-35 [**2131-10-13**] 03:03AM   GLUCOSE-94 LACTATE-1.2 NA+-145 K+-4.1 CL--104 TCO2-31* [**2131-10-13**] 03:03AM   PO2-114* PCO2-61* PH-7.32* TOTAL CO2-31* BASE XS-3 COMMENTS-GREEN TOP [**2131-10-13**] 04:55AM   LACTATE-1.8 K+-4.1 [**2131-10-13**] 04:55AM   COMMENTS-GREEN TOP [**2131-10-13**] 06:24AM   PLT SMR-NORMAL PLT COUNT-324 [**2131-10-13**] 06:24AM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-OCCASIONAL MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL OVALOCYT-OCCASIONAL [**2131-10-13**] 06:24AM   NEUTS-87* BANDS-0 LYMPHS-6* MONOS-6 EOS-1 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2131-10-13**] 06:24AM   WBC-13.0* RBC-3.53* HGB-10.4* HCT-32.4* MCV-92 MCH-29.5 MCHC-32.1 RDW-16.1* [**2131-10-13**] 06:24AM   CALCIUM-8.2* PHOSPHATE-5.1* MAGNESIUM-2.0 [**2131-10-13**] 06:24AM   CK-MB-4 cTropnT-0.03* [**2131-10-13**] 06:24AM   ALT(SGPT)-19 AST(SGOT)-19 CK(CPK)-117 ALK PHOS-68 TOT BILI-0.4 [**2131-10-13**] 06:24AM   GLUCOSE-125* UREA N-32* CREAT-1.1 SODIUM-147* POTASSIUM-4.6 CHLORIDE-108 TOTAL CO2-30 ANION GAP-14 [**2131-10-13**] 06:30AM   LACTATE-1.6 [**2131-10-13**] 06:30AM   TYPE-[**Last Name (un) **] TEMP-35.9 PO2-32* PCO2-59* PH-7.36 TOTAL CO2-35* BASE XS-5 [**2131-10-13**] 04:41PM   PT-13.4 PTT-24.4 INR(PT)-1.1 [**2131-10-13**] 04:41PM   PLT COUNT-292 [**2131-10-13**] 04:41PM   WBC-11.2* RBC-3.74* HGB-10.9* HCT-32.6* MCV-87 MCH-29.0 MCHC-33.3 RDW-16.0* [**2131-10-13**] 04:41PM   ALBUMIN-3.4* CALCIUM-8.1* PHOSPHATE-4.9* MAGNESIUM-2.0 [**2131-10-13**] 04:41PM   CK-MB-3 cTropnT-0.03* [**2131-10-13**] 04:41PM   CK(CPK)-114 [**2131-10-13**] 04:41PM   GLUCOSE-118* SODIUM-145 POTASSIUM-4.3 CHLORIDE-105 TOTAL CO2-31 ANION GAP-13  CT Head: IMPRESSION: 1.
MRI with gadolinium would be recommended for further evaluation.
Extensive nasal passage and sinus opacification compatible with intubated status.
Post-surgical appearance to the left globe, correlate clinically.
[**2131-10-13**] 4:30 am BLOOD CULTURE     Blood Culture, Routine (Pending):  [**2131-10-13**] 12:08 pm SPUTUM      Source: Endotracheal.
Port placement [**2131-10-16**]: IMPRESSION: Successful placement of double-lumen chest Power Port-A-Cath via right internal jugular venous access.
[**2131-10-18**] 04:40AM BLOOD WBC-12.7* RBC-3.62* Hgb-10.9* Hct-32.7* MCV-90 MCH-30.1 MCHC-33.3 RDW-15.7* Plt Ct-326 [**2131-10-18**] 04:40AM BLOOD Glucose-178* UreaN-34* Creat-1.0 Na-144 K-3.8 Cl-108 HCO3-30 AnGap-10 [**2131-10-18**] 04:40AM BLOOD Calcium-7.9* Phos-2.9 Mg-1.9  Brief Hospital Course: Valeriy [**Known lastname 95456**] is a 71-year-old right-handed Russian-speaking male with DM, CAD s/p IMI, recent diagnosis of right frontotemporal glioma s/p biopsy intubated for hypoxemic respiratory failure.
Patient was diuresed with furosemide and was net (-) 5 liters 36 hours after admission.
Received total of metoprolol tartrate 20 mg IV to slow rate.
Aspirin was held given his glioblastoma and stable intracranial hemorrhage.
Overlying pneumonia could not be excluded based on chest film, and broad spectrum antibiotics were continued for 48 hours, later discontinued after sputum results returned.
Patient was continued on Lasix while admitted to prevent against respiratory symptoms and to improve edema, which was significant in the upper and lower extremities.
(2) Postoperative Cerebral Edema and Mass Effect:  There was no midline shift by CT.  Neurosurgery was consulted and did not recommend surgical intervention.
Following extubation and continued improvement in patient's hemodynamics, transfer was arranged to the [**Hospital Ward Name 516**] for continued management of glioblastoma multiforme.
(3) Glioblastoma Multiforme:  The patient had a portcath placed on [**2131-10-16**] and began radiation treatment on [**2131-10-17**] without incident.
[**Name (NI) **] was continued on home dose of Keppra during the admission.
Patient will require 42 treatments for radiation, the next is scheduled for [**2131-10-19**] at 02:30 pm at [**Hospital1 18**], in the [**Hospital Ward Name 332**] basement.
Hypertensive regimen was altered while admitted.
The patient was continued on his home clonidine and valsartan regimen.
Labetalol dose was increased from 600 mg [**Hospital1 **] to 800 mg [**Hospital1 **] for added control.
In addition, Lasix was given, final dose 60 mg [**Hospital1 **] upon discharge.
IF need additional control, neuro-oncology advises trying hydralazine as this can improve cerebral pressure as well as systemic pressure.
(5) Chronic Diastolic CHF:  Patient was placed on Lasix during admission for edematous symptoms and to prevent respiratory symptoms.
He was dicharged on  60 mg po BID.
(7) Anxiety:  He continued buspar, klonopin to avoid withdrawal symptoms.
Medications on Admission: Labetolol 600 mg [**Hospital1 **] Eplerenone 50 mg daily Clonidine 0.4 mg patch weekly Colace 100 mg [**Hospital1 **] Decadron 2 mg TID, taper Lantus 40 mg qhs Novolog 9U QAC Keppra 500 mg [**Hospital1 **] Diovan 160 mg [**Hospital1 **] Zocor 40 mg daily Klonopin 0.5 mg qhs Metformin 500 mg [**Hospital1 **] Buspar 5 mg [**Hospital1 **] Colace 100 mg [**Hospital1 **]  Discharge Medications: 1.
Buspirone 5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Clonidine 0.2 mg/24 hr Patch Weekly Sig: Two (2) Patch Weekly Transdermal QSAT (every Saturday).
Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.
Klonopin 0.5 mg Tablet Sig: One (1) Tablet PO at bedtime.
Valsartan 160 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Dexamethasone 2 mg Tablet Sig: 1.5 Tablets PO Q6H (every 6 hours).
Lantus 100 unit/mL Cartridge Sig: 60  Units Subcutaneous at bedtime.
Temozolomide 140 mg Capsule Sig: One (1) Capsule PO once a day.
Temozolomide 5 mg Capsule Sig: Three (3) Capsule PO once a day.
Eplerenone 50 mg Tablet Sig: One (1) Tablet PO once a day.
Novolog 100 unit/mL Cartridge Sig: Nine (9) Units Subcutaneous QAC.
Furosemide 20 mg Tablet Sig: Three (3) Tablet PO BID (2 times a day).
Labetalol 200 mg Tablet Sig: Four (4) Tablet PO twice a day.
Discharge Disposition: Extended Care  Facility: [**Hospital 4542**] Rehabilitation and Nursing of [**Location (un) 38**]  Discharge Diagnosis: Primary dianosis: Hypoxemic respiratory failure Postoperative cerebral edema and mass effect Hypertensive urgency  Secondary diagnosis: Right frontotemporal glioblastoma multiforme Malignant hypertension Coronary artery disease Chronic diastolic congestive heart failure Paroxysmal atrial fibrillation Diabetes mellitus Anxiety  Discharge Condition: Mental Status: Clear and coherent.
While you were here we adjusted your heart failure and blood pressure medications to more optimally manage these problems.
It is important that you continue to take your medications as prescribed.
The following changes have been made to your medications:  We INCREASED your labetalol dose to better control your blood pressure We STARTED lasix to better control your heart failure.
We INCREASED your decadron while you are receiving radiation to the brain.
Please continue to take your chemotherapy as directed by Dr. [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) 724**].
